Biomolecules & Therapeutics · 2008 · 32 citations · 15 references
Pain MedicineNitric OxideImmunologyMolecular PainPharmacotherapyExperimental PharmacologyOxidative StressInflammationMolecular PharmacologyMedicinal ChemistryIcr MiceRaw264.7 MacrophagesCurrent StudyVascular PharmacologyPharmacological AgentVascular BiologyPharmacologyPain ResearchAnti-inflammatoryMedicineDrug Discovery
The current study aimed to assess some novel pharmacological activities of vanillin. Vanillin inhibited the chick chorioallantoic membrane (CAM) angiogenesis. Vanillin had anti-inflammatory activity using the acetic acid-induced permeability model in mice. Anti-nociceptive activity of vanillin was shown using the acetic acid-induced writhing test in mice. Vanillin inhibited production of nitric oxide (NO) and induction of inducible nitric oxide synthase (iNOS) but not cyclooxygenase-2 (COX-2) in the lipopolysaccharide (LPS)-activated RAW264.7 macrophages. Vanillin decreased the level of iNOS mRNA in the LPS-activated macrophages. Taken together, these results suggest that vanillin can have anti-angiogenic, anti-inflammatory and anti-nociceptive activities in ICR Mice.
15
Holly M. Brown‐Borg · Tissue and Cell · 1995 · 516 citations
Michael P. Sherman, Ernesto E. Aeberhard, Vivian Wong et al. · Biochemical and Biophysical Research Communications · 1993 · 250 citations
Inflammation, Anti-inflammatory, Inflammatory Lung Disease +10